Celularity financials
$1.37−2.14%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 | Q2 '23 Jun 30 | Q1 '23 Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.1M | $5.3M | $5.7M | $11.4M | $18.1M | $9.3M | $12.1M | $14.7M | $12.1M | $3.8M | $2.9M | $3.9M |
| Gross profit | -$3.3M | $1.4M | $494.0K | $7.9M | $10.8M | $5.4M | $10.0M | $13.0M | $2.5M | $184.0K | $2.1M | $1.9M |
| Gross margin | −79.7% | 26.1% | 8.6% | 68.9% | 59.5% | 58.2% | 82.5% | 88.8% | 20.7% | 4.9% | 72.7% | 49.1% |
| Operating income | -$22.1M | -$12.9M | -$15.9M | -$10.5M | -$9.3M | -$11.5M | -$10.2M | -$7.4M | $13.3M | -$99.3M | -$42.5M | -$63.9M |
| Net income | -$24.4M | -$23.1M | -$24.5M | -$19.8M | -$13.3M | -$16.1M | -$6.5M | -$22.0M | $9.5M | -$93.9M | -$47.9M | -$64.0M |
| Net margin | −595.7% | −436.7% | −427.5% | −173.4% | −73.3% | −173.2% | −53.6% | −149.9% | 78.8% | −2479.6% | −1632.0% | −1626.9% |
| Diluted EPS | $-0.86 | $-0.88 | $-1.02 | $-0.84 | $-0.60 | $-0.73 | $-0.30 | $-1.03 | $0.50 | $-4.98 | $-2.72 | $-4.12 |
| EBITDA | -$20.2M | -$11.1M | -$14.0M | -$8.7M | -$7.6M | -$9.6M | -$8.2M | -$5.2M | $19.1M | -$14.2M | $67.6M | -$50.8M |
| Operating cash flow | -$5.1M | -$4.2M | -$999.0K | -$3.0M | $1.6M | -$144.0K | -$3.4M | -$4.4M | -$4.3M | $93.0M | -$27.0M | $937.0K |
| Free cash flow | -$5.1M | -$4.2M | -$999.0K | -$3.0M | $3.0K | -$144.0K | -$3.5M | -$4.4M | -$4.9M | $92.8M | -$27.0M | $728.0K |
| Diluted shares | 28.5M | 26.3M | 24.0M | 23.5M | 22.3M | 22.0M | 21.8M | 21.4M | 19.2M | 18.8M | 17.7M | 15.5M |
Balance sheet
| Period end | Dec 31 | Sep 30 | Jun 30 | Mar 31 | Dec 31 | Sep 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.2M | $120.0K | $863.0K | $293.0K | $738.0K | $133.0K |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $47.8M | $35.7M | $2.6M | $2.5M | $6.4M | $3.7M |
| Total assets | $107.3M | $114.2M | $120.3M | $128.9M | $132.7M | $128.8M |
| Total liabilities | $145.4M | $134.3M | $145.8M | $134.4M | $123.8M | $111.6M |
| Shareholders' equity | -$38.1M | -$20.1M | -$25.5M | -$5.5M | $8.8M | $17.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology